Comprehensive historical analysis of global market for Hereditary Angioedema Therapeutics has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2023-2032 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the Hereditary Angioedema Therapeutics market.

The Global Hereditary angioedema therapeutics market Size is expected to grow from USD 3.65 billion in 2025 to USD 9.89 billion by 2035, at a CAGR of 10.48% during the forecast period 2026-2035. 

The report includes growth prospects in the global Hereditary Angioedema Therapeutics market by type, application, sub segement and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.

Leading players of Hereditary Angioedema Therapeutics including:

1. Takeda Pharmaceutical Company Limited
2. CSL Behring
3. Pharming Group N.V.
4. BioCryst Pharmaceuticals, Inc.
5. KalVista Pharmaceuticals, Inc.
6. Ionis Pharmaceuticals, Inc.
7. Sanofi S.A.
8. Shire plc
9. Attune Pharmaceuticals, Inc.
10. Adverum Biotechnologies, Inc.
11. Arrowhead Pharmaceuticals, Inc.
12. Octapharma AG

Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/4728

Market split by Segement, can be divided into:

By Treatment Type

• Hormonal Therapy
• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Antimicrobial Therapy
• Others

 By Route of Administration

• Oral
• Parenteral

Market segment by Region/Country including:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

Check discount for this report: https://www.sphericalinsights.com/request-discount/4728

In December 2025, as new hereditary angioedema (HAE) drugs had flooded the market, questions arose about whether uptake had matched innovation. The influx of advanced therapies expanded treatment options, improved patient outcomes, and strengthened competition, positively shaping the global HAE therapeutics landscape with broader accessibility and innovation-driven growth.

In October 2025, BioCryst Pharmaceuticals announced the acquisition of Astria Therapeutics in a deal worth about $700 million, which strengthened its rare disease and hereditary angioedema (HAE) pipeline. This strategic move expanded BioCryst’s portfolio with innovative long-acting therapies, enhancing its competitive position in the global HAE therapeutics market.

In June 2025, Companies had increasingly formed regional commercialization partnerships, with KalVista collaborating with partners to expand its market presence in Asia. These alliances strengthened distribution networks, improved patient access to hereditary angioedema (HAE) therapies, and supported growth in emerging markets, positively impacting the global HAE therapeutics landscape.

In April 2025, Strategic collaborations between biotech firms and research organizations had accelerated clinical trials and pipeline development for novel kallikrein inhibitors and monoclonal antibodies. These partnerships strengthened innovation, advanced rare disease research, and expanded therapeutic options, positively impacting the global hereditary angioedema (HAE) therapeutics market.

Access full Report with Table of Content @ https://www.decisionsadvisors.com/reports/hereditary-angioedema-therapeutics-market

Whats covered in the report?

• 1. Overview of the Hereditary Angioedema Therapeutics market.
• 2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the Hereditary Angioedema Therapeutics market, based on segement.
• 3. Hereditary Angioedema Therapeutics Market trends.
• 4. Hereditary Angioedema Therapeutics Market drivers.
• 5. Analysis of major company profiles.

Reasons to buy this Market Report:

1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Hereditary Angioedema Therapeutics market.
2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging Hereditary Angioedema Therapeutics Industry.
3. Leading company profiles reveal details of key Hereditary Angioedema Therapeutics market players emerging five operations and financial performance.
4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging Hereditary Angioedema Therapeutics market with five year historical forecasts.
5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.
6. Extensive information on factors that will amplify the growth of the Hereditary Angioedema Therapeutics market over the upcoming seven years
7. Accurate estimation of the global Hereditary Angioedema Therapeutics market size
8. Exact estimations of the upcoming trends and changes observed in the consumer behavior
9. Growth of the global Hereditary Angioedema Therapeutics market across the North & South America, EMEA, Asia Pacific, and Latin America
10. Information about Hereditary Angioedema Therapeutics market growth potential
11. In-depth analysis of the industry’s competitive landscape and detailed information vis-a-vis on various vendors
12. Furnishing of detailed information on the factors that will restrain the growth of the Hereditary Angioedema Therapeutics market

About the Spherical Insights

Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:

Company Name: Spherical Insights

Email: [email protected]

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter